Literature DB >> 11794092

Health for all in Pakistan: achievements, strategies and challenges.

S Z Ali1.   

Abstract

This paper describes Pakistan's progress towards achieving health for all. Strategies and achievements are discussed, with particular reference to political commitment, community participation and programme development. The challenges faced by the country in achieving health for all are described and the future prospects outlined.

Mesh:

Year:  2000        PMID: 11794092

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  5 in total

1.  Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Rasool Bux; Neil Poulter; Juanita Hatcher; Nish Chaturvedi; Shah Ebrahim; Peter Cosgrove
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  Molecular relationship between field and vaccine strain of measles virus and its persistence in Pakistan.

Authors:  Masaud Shah; Sulaiman Shams; Ziaur Rahman
Journal:  Genet Vaccines Ther       Date:  2012-01-30

Review 3.  Why Have Immunization Efforts in Pakistan Failed to Achieve Global Standards of Vaccination Uptake and Infectious Disease Control?

Authors:  Mahreen Butt; Raihan Mohammed; Eman Butt; Sundas Butt; Jinpo Xiang
Journal:  Risk Manag Healthc Policy       Date:  2020-02-12

4.  Prevalence of measles in vaccinated and non-vaccinated children.

Authors:  Muhammad Asif Zahoor; Muhammad Hidayat Rasool; Muhammad Waseem; Bilal Aslam; Muhammad Kashif Zahoor; Muhammad Saqalein; Zeeshan Nawaz; Rabia Sahar
Journal:  EXCLI J       Date:  2015-04-01       Impact factor: 4.068

5.  ELISA for detection of humoral immunity against measles.

Authors:  Muhammad Asif Zahoor; Muhammad Saqalein; Zeeshan Nawaz
Journal:  EXCLI J       Date:  2015-10-20       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.